triclabendazole
Selected indexed studies
- Triclabendazole in the treatment of human fascioliasis: a review. (Trans R Soc Trop Med Hyg, 2019) [PMID:31638149]
- Understanding triclabendazole resistance. (Exp Mol Pathol, 2007) [PMID:17398281]
- Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures. (Expert Rev Anti Infect Ther, 2021) [PMID:33267701]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Triclabendazole in the treatment of human fascioliasis: a review. (2019) pubmed
- Understanding triclabendazole resistance. (2007) pubmed
- Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures. (2021) pubmed
- Triclabendazole for the treatment of fascioliasis and paragonimiasis. (2005) pubmed
- Triclabendazole for the treatment of fascioliasis. (2019) pubmed
- Triclabendazole progress report, 2005-2009: an advancement of learning? (2009) pubmed
- Triclabendazole: new skills to unravel an old(ish) enigma. (2005) pubmed
- [Triclabendazole]. (2010) pubmed
- Current Threat of Triclabendazole Resistance in Fasciola hepatica. (2016) pubmed
- Suspected triclabendazole resistance in ewes with chronic fasciolosis. (2021) pubmed